Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent CXCR4 antagonist and an anti-angiogenic drug that is of potential value in treating choroid neovascularization.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 990 | 6-8周 | ||
10 mg | ¥ 1,580 | 6-8周 | ||
25 mg | ¥ 2,850 | 6-8周 | ||
50 mg | ¥ 4,640 | 6-8周 | ||
100 mg | ¥ 7,170 | 6-8周 | ||
200 mg | ¥ 11,800 | 6-8周 | ||
500 mg | ¥ 23,800 | 6-8周 |
产品描述 | Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent CXCR4 antagonist and an anti-angiogenic drug that is of potential value in treating choroid neovascularization. |
体外活性 | Burixafor hydrobromide mobilizes mesenchymal stem cells, attenuates inflammation, and preserves cardiac systolic function in a porcine model of myocardial infarction [2]. |
别名 | TG-0054 hydrobromide |
分子量 | 647.644 |
分子式 | C27H52BrN8O3P |
CAS No. | 1191450-19-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 50 mg/mL (65.02 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O | 1 mM | 1.5441 mL | 7.7203 mL | 15.4406 mL | 38.6015 mL |
5 mM | 0.3088 mL | 1.5441 mL | 3.0881 mL | 7.7203 mL | |
10 mM | 0.1544 mL | 0.772 mL | 1.5441 mL | 3.8601 mL | |
20 mM | 0.0772 mL | 0.386 mL | 0.772 mL | 1.9301 mL | |
50 mM | 0.0309 mL | 0.1544 mL | 0.3088 mL | 0.772 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Burixafor hydrobromide 1191450-19-7 Autophagy GPCR/G Protein Immunology/Inflammation CXCR TG 0054 Hydrobromide TG-0054 Hydrobromide TG0054 Hydrobromide Burixafor Hydrobromide TG-0054 hydrobromide Inhibitor inhibitor inhibit